Screening of anti-hypoxia/reoxygenation agents by an in vitro model. Part 1: Natural inhibitors for protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells

Planta Medica

Volumn 66, Issue 2, 2000, Pages 114-118

  Zhang, You Wei ^a,b   Morita, Ikuo ^a   Shao, Gang ^b   Yao, Xin Sheng ^b   Murota, Sei Itsu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioactive compounds; Hypoxia reoxygenation; Ischemia reperfusion; Protein tyrosine kinase; Tyrosine phosphorylated proteins

Indexed keywords

CHINENOSIDE; GINSENOSIDE; ICARIIN; ICARITIN; LAXOGENIN 3 O BETA XYLOPYRANOSYL(1-4)ALPHA ARABINOPYRANOSYL(1-6)BETA GLUCOPYRANOSIDE; MACROSTEMOSOSIDE A; PROTEIN TYROSINE KINASE INHIBITOR; SITOSTEROL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPOXIA; REOXYGENATION; REPERFUSION INJURY; UMBILICAL VEIN;

CELL HYPOXIA; CELLS, CULTURED; DRUGS, CHINESE HERBAL; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; PERFUSION; PROTEIN-TYROSINE KINASES; REPERFUSION INJURY; UMBILICAL VEINS;

EID: 0034023515     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-11128     Document Type: Article

References (20)

1. 1 McMcord JM. N. Engl. J. Med. 1985; 312: 159-163
2. 2 Gallagher KP, Buda AJ, Pace D, Gerren RA, Shlafer M. Circulation 1986: 73: 1065-1076
3. 3 Uraizer A, Reimer KA, Murry CE, Jennings RB. Circulation 1987; 75: 1237-1248
4. 4 Richard VJ, Murry CE, Jennings RB, Reimer KA. Circulation 1988; 78: 473-480
5. 5 Nejima J, Knight DR, Fallon JT, Uemura N, Manders WT, Canfield DR, Cohen MV, Vatner SF. Circulation 1989; 79: 143-153
6. 6 Patel B, Jeroudi MO, O'Neill PG, Roberts R, Bolli R. Circulation 1988; 78: 373
7. 7 Shirato C, Miura T, Downey JM. FASEB J. 1988; 2: A918
8. 8 Caldwell-Kenkel JC, Currin RT, Coote A, Thurman RG, Lemasters JJ. Transplant. Int. 1995; 8: 77-85
9. 9 Terada LS. Am. J. Physiol. 1996; 270: H945-H950
10. 10 Chen Y, Yu A, Saari JT, Kang YT. Proc. Soc. Exp. Biol. Med. 1997; 216: 112-116
11. 11 Campos-Gonzalez R, Kindy MS. J. Neurochem. 1992; 59: 1955-1958
12. 12 Hayashi A, Imai K, Kim HC, de Juan E Jr. Invest. Ophthalmol. Vis. Sci. 1997; 38: 372-380
13. 13 Hayashi A, Koroma BM, Imai K, de Juan E Jr. Invest. Ophthalmol. Vis. Sci. 1996; 37: 2146-2156
14. 14 Korematsu K, Goto S, Nagashiro S, Inoue N, Oyama T, Yamada K, Ushio Y. GLIA. 1995; 13: 147-153
15. 15 Korematsu K, Goto S, Nagashi S, Ushio Y. J. Cereb. Blood Flow Metab. 1994; 14: 825-830
16. 16 Kindy MS. J. Cereb. Blood Flow Metab. 1993; 13: 372-377
17. 17 Phillis JW, Song D, O'Regan MH. Neuroscience Lett. 1996; 207: 151-154
18. 18 Hayashi A, Weinberger AW, Kim HC, de Juan E Jr. Invest. Ophthalmol. Vis. Sci. 1997; 38: 1193-1202
19. 19 Hagar H, Ueda N, Shan SV. Kidney Int. 1997; 51: 1747-1753
20. 20 Crawford LE, Milliken EE, Irani K, Zweier JL, Becker LC, Johanson TM, Eissa NT, Crystal RG, Finkel T, Goldschmidt-Clermont PT. J. Biol. Chem. 1996; 271: 2683-2687